ABSTRACT
Cellular and regenerative medicine technologies are poised to improve treatment options and health outcomes in a variety of disease areas in the coming years. These innovative technologies not only hold the potential to transform healthcare in a manner similar to the ways in which monoclonal antibodies and other biologics have done so over the past decade. Some may even offer cures or prolonged therapeutic effects in certain chronic diseases.
